Innovative Product — “Reewarm ® PTX” is Approved by NMPA
On April 29, 2020, NMPA approved the registration of an innovative device — “Reewarm ® PTX” from Shanghai MicroPort Endovascular MedTech Co., Ltd. The product is used for balloon dilation of the femoral popliteal artery (except the inferior genu artery) in percutaneous intracavitary angioplasty to treat atherosclerotic stenosis or occlusion.
